News

Aimed at advancing the company’s first clinical candidate into preclinical studies, the three-year grant will particularly support non-human primate efficacy studies, mechanism of action experiments, and discovery of

Therapeutically equivalent to Depo-Testosterone Injection of Pfizer, the Testosterone Cypionate Injection USP, 100 mg/mL and 200mg/mL is indicated for males with deficiency or absence of endogenous testosterone. The

Featuring PerkinElmer’s Flick-to-Share technology, both ChemDraw and Chem3D apps will enable scientists to collaborate and share critical information in real-time in and out of the laboratory. PerkinElmer vice

Under the contract, early stage proof-of-concept feasibility process development will be conducted to identify concentrating AVA filtrate for storage before the downstream process for vaccine. GBI process development

The world’s first FD treatment, Acofide demonstrated efficacy in FD patients diagnosed by the international diagnostic criteria for functional gastrointestinal diseases, the Rome III. Both the companies will

Under the agreement, a whole genome mapping module was incorporated by Applied Maths into the company’s new BioNumerics 7 software suite. With the new software tool, customers can

Indicated for the topical treatment of mild to moderate atopic dermatitis in patients aged three months and more, Verdeso foam is emollient-based, ethanol-free and unavailable in generic form.

MOR103 has concluded Phase 1/2 development in mild to moderate rheumatoid arthritis. As per the terms of the agreement, MorphoSys will receive from GSK $29.3m (€22.5m) as immediate

Acadia CEO Uli Hacksell said that the molecule has demonstrated an attractive profile and has distinctly different properties from other glaucoma compounds advanced under the collaboration. Both the